- Home
- ARRY vs OCUL Comparison
ARRY vs OCUL Comparison
Compare ARRY & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARRY
- OCUL
- Stock Information
- Founded
- ARRY 1989
- OCUL 2006
- Country
- ARRY United States
- OCUL United States
- Employees
- ARRY N/A
- OCUL N/A
- Industry
- ARRY Semiconductors
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- ARRY Technology
- OCUL Health Care
- Exchange
- ARRY Nasdaq
- OCUL Nasdaq
- Market Cap
- ARRY 1.1B
- OCUL 1.2B
- IPO Year
- ARRY 2020
- OCUL 2014
- Fundamental
- Price
- ARRY $6.59
- OCUL $7.00
- Analyst Decision
- ARRY Buy
- OCUL Strong Buy
- Analyst Count
- ARRY 22
- OCUL 7
- Target Price
- ARRY $12.18
- OCUL $16.71
- AVG Volume (30 Days)
- ARRY 4.4M
- OCUL 940.9K
- Earning Date
- ARRY 02-27-2025
- OCUL 03-10-2025
- Dividend Yield
- ARRY N/A
- OCUL N/A
- EPS Growth
- ARRY N/A
- OCUL N/A
- EPS
- ARRY N/A
- OCUL N/A
- Revenue
- ARRY $982,190,000.00
- OCUL $61,442,000.00
- Revenue This Year
- ARRY N/A
- OCUL $11.40
- Revenue Next Year
- ARRY $23.37
- OCUL $13.58
- P/E Ratio
- ARRY N/A
- OCUL N/A
- Revenue Growth
- ARRY N/A
- OCUL 6.45
- 52 Week Low
- ARRY $5.15
- OCUL $4.06
- 52 Week High
- ARRY $15.35
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- ARRY 46.10
- OCUL 31.92
- Support Level
- ARRY $6.49
- OCUL $7.14
- Resistance Level
- ARRY $7.21
- OCUL $7.42
- Average True Range (ATR)
- ARRY 0.49
- OCUL 0.37
- MACD
- ARRY -0.07
- OCUL -0.02
- Stochastic Oscillator
- ARRY 12.59
- OCUL 0.76
About ARRY Array Technologies Inc.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.